AstraZeneca gets CDSCO panel Nod To study antihypertensive drug Baxdrostat Dr. Divya Colin9 Dec 2023 9:34 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Novartis Gets CDSCO Panel Nod to study Remibrutinib to treat chronic spontaneous urticaria Dr. Divya Colin8 Dec 2023 6:00 PM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Potassium-Competitive Acid Blockers (P- CABs) for GERD Management - Potential Game Changer or Washout? Dr Jeegar Dattani7 Dec 2023 11:30 AM ISTProton pump Inhibitors have been used globally for the management of gastroesophageal disease (GERD) and Acid Peptic Disease (APD) for a long time....
Conduct post marketing clinical study to generate safety data of Nerivio: CDSCO panel Tells Dr Reddy's Lab Dr. Divya Colin6 Dec 2023 6:00 PM ISTNew Delhi: Considering the drug major Dr. Reddys Laboratorie's proposal to import the Nerve Electrical Stimulator (Brand Name: Nerivio) intended for...
HC relief to Sun Pharma, restrains Delhi firm from using ABBZORB mark for health supplements similar to ABZORB Farhat Nasim5 Dec 2023 4:47 PM ISTNew Delhi: In a major respite to Sun Pharmaceutical Industries Ltd., the Delhi High Court has restrained Protrition Products LLP & Ors., a...
Drug Safety Alert: Indian Pharmacopoeia Commission flags adverse drug reaction linked to Mefenamic Acid Susmita Roy4 Dec 2023 5:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of November, has revealed that a...
Akum Pharmaceutical Gets CDSCO Panel Nod to Manufacture, Market Azelnidipine, Metoprolol FDC tablet Dr. Divya Colin3 Dec 2023 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Include Ankle Brachial Index test to exclude peripheral artery disease: CDSCO Panel Tells Lupin on Denosumab PK/PD study Dr. Divya Colin2 Dec 2023 6:00 PM ISTNew Delhi: The drug major Lupin has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Dr. Reddy's Gets CDSCO Panel Nod to Study FDC Etoricoxib plus Thiocolchicoside for Export purpose Dr. Divya Colin1 Dec 2023 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Submit Justification to study Tocilizumab in patients with giant cell arteritis: CDSCO Panel Tells Cipla Dr. Divya Colin30 Nov 2023 6:00 PM ISTNew Delhi: Reviewing the protocol presented by the drug major Cipla for the approval post-marketing active surveillance of Tocilizumab in patients of...
Allahabad HC relief to Medical Representative who was terminated for allegedly lying about doctor visits Adity Saha29 Nov 2023 3:52 PM ISTThe court also upheld medical representatives as workmen under the Industrial Disputes Act of 1947
Conduct bioequivalence study: CDSCO Panel Tells Lupin on FDC Indacaterol, Glycopyrronium inhalation powder Dr. Divya Colin28 Nov 2023 6:00 PM ISTNew Delhi: Rejecting the justification for the waiver of the bioequivalence study (BE) and Phase III clinical study of fixed-dose combination (FDC)...
